This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsMTL Cannabis（MTLC）株式概要MTL Cannabis Corp.は子会社を通じて、カナダで娯楽用および医療用の大麻製品の栽培と生産に従事している。 詳細MTLC ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性2/6配当金0/6リスク分析利払いは収益で十分にカバーされない 意味のある時価総額がありません ( CA$69M )すべてのリスクチェックを見るMTLC Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW500,622 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINROAG500,622 investors already sharing narrativesYour Fair ValueCA$Current PriceCA$0.5790.1% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-5m343m2016201920222025202620282031Revenue CA$343.1mEarnings CA$50.5mAdvancedSet Fair ValueView all narrativesMTL Cannabis Corp. 競合他社Decibel CannabisSymbol: TSXV:DBMarket cap: CA$66.4mVext ScienceSymbol: CNSX:VEXTMarket cap: CA$55.7mPlanet 13 HoldingsSymbol: CNSX:PLTHMarket cap: CA$65.4mGrown Rogue InternationalSymbol: CNSX:GRINMarket cap: CA$165.0m価格と性能株価の高値、安値、推移の概要MTL Cannabis過去の株価現在の株価CA$0.5752週高値CA$1.0352週安値CA$0.29ベータ-0.511ヶ月の変化-1.72%3ヶ月変化-32.94%1年変化72.73%3年間の変化n/a5年間の変化n/aIPOからの変化14.00%最新ニュースReported Earnings • Mar 02Third quarter 2026 earnings released: EPS: CA$0.006 (vs CA$0.01 loss in 3Q 2025)Third quarter 2026 results: EPS: CA$0.006 (up from CA$0.01 loss in 3Q 2025). Revenue: CA$17.2m (down 14% from 3Q 2025). Net income: CA$672.9k (up CA$1.89m from 3Q 2025). Profit margin: 3.9% (up from net loss in 3Q 2025). The move to profitability was driven by lower expenses.Buy Or Sell Opportunity • Dec 15Now 80% overvalued after recent price riseOver the last 90 days, the stock has risen 22% to CA$0.77. The fair value is estimated to be CA$0.43, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 41% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Dec 15Canopy Growth Corporation (TSX:WEED) entered into an arrangement agreement to acquire MTL Cannabis Corp. (CNSX:MTLC) for approximately CAD 120 million.Canopy Growth Corporation (TSX:WEED) entered into an arrangement agreement to acquire MTL Cannabis Corp. (CNSX:MTLC) for approximately CAD 120 million on December 14, 2025. Canopy Growth to acquire all of the issued and outstanding common shares in the capital of MTL on the basis of 0.32 of a common share of Canopy Growth (each whole share, a “Canopy Growth Share”) and CAD 0.144 in cash for each MTL Share, or approximately 38 million Canopy Growth Shares and CAD 17 million in cash in the aggregate. Pursuant to the Arrangement, each MC Shareholder will irrevocably, finally and fully release MTL, Canopy Growth and their respective affiliates from any and all obligations owing to such MC Shareholder pursuant to the Share Exchange Agreement, including for greater certainty, each MC Shareholder’s entitlement to anti-dilution rights pursuant to the Share Exchange Agreement (the “Release”) in exchange for such MC Shareholder’s pro rata entitlement to up to 2,956,391 (subject to reduction in certain circumstances) Canopy Growth Shares to be issued to the MC Shareholders pursuant to the Arrangement. The. Arrangement Agreement provides that a termination fee of CAD 4 million (the “Termination Fee”) will be payable by MTL upon termination of the Arrangement Agreement. Haywood Securities Inc. provided the MTL Cannabis Special Committee with an opinion that, as of December 14, 2025 and based upon and subject to the various assumptions, limitations, qualifications and other matters set forth in such opinion, the consideration to be received by the MTL Shareholders pursuant to the Transaction is fair, from a financial point of view, to MTL Shareholders. The Transaction was unanimously approved by the Board of Directors of Canopy Growth, as well as the Board of Directors of MTL Cannabis (with conflicted directors abstaining), following the unanimous recommendation of a special committee of the MTL Board of Directors (the “MTL Special Committee”). The MTL Special Committee and the Board of Directors unanimously recommended that MTL Shareholders vote in favour of the Transaction after determining the Transaction is fair to the MTL Shareholders and is in the best interests of MTL Cannabis. The Arrangement is subject to the conditions set forth in the Arrangement Agreement, including, among others: (i) approval by the Supreme Court of British Columbia (the “Court”) at a hearing upon the procedural and substantive fairness of the terms and conditions of the Arrangement; (ii) any approvals required under the Competition Act (Canada); and (iii) approval by the shareholders of MTL as required by applicable corporate and securities laws. The shareholders of MTL will be asked to vote on a resolution (the “Arrangement Resolution”) to, among other things, approve the Arrangement at a shareholder meeting to be called for such purpose, certain regulatory approvals, conditional approval of the Toronto Stock Exchange will have been obtained, including in respect of the listing and posting for trading of the Canopy Growth Shares issued as consideration for MTL Shares pursuant to the Arrangement and the MC Shareholder Consideration. Special meeting of MTL shareholders is expected to occur in February 2026, Expected closing by the end of February 2026. Jonathan Sherman of Cassels Brock& Blackwell LLP acted as legal advisor to Canopy Growth Corporation, Daniel Everall?of Farris LLP acted as legal advisor to MTL, Canaccord Genuity Corp. is acting as exclusive financial advisor to Canopy Growth. Paul Hastings LLP are acting as legal counsel to the Company, Haywood Securities Inc. is acting as exclusive financial advisor to the MTL Special Committee and provided a fairness opinion to the MTL Special Committee.New Risk • Dec 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.3x net interest cover). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Market cap is less than US$100m (CA$49.3m market cap, or US$35.8m).分析記事 • Nov 30Market Cool On MTL Cannabis Corp.'s (CSE:MTLC) Revenues Pushing Shares 32% LowerTo the annoyance of some shareholders, MTL Cannabis Corp. ( CSE:MTLC ) shares are down a considerable 32% in the last...Reported Earnings • Nov 30Second quarter 2026 earnings released: CA$0.071 loss per share (vs CA$0.011 profit in 2Q 2025)Second quarter 2026 results: CA$0.071 loss per share (down from CA$0.011 profit in 2Q 2025). Revenue: CA$20.6m (down 1.2% from 2Q 2025). Net loss: CA$8.32m (down CA$9.57m from profit in 2Q 2025).最新情報をもっと見るRecent updatesReported Earnings • Mar 02Third quarter 2026 earnings released: EPS: CA$0.006 (vs CA$0.01 loss in 3Q 2025)Third quarter 2026 results: EPS: CA$0.006 (up from CA$0.01 loss in 3Q 2025). Revenue: CA$17.2m (down 14% from 3Q 2025). Net income: CA$672.9k (up CA$1.89m from 3Q 2025). Profit margin: 3.9% (up from net loss in 3Q 2025). The move to profitability was driven by lower expenses.Buy Or Sell Opportunity • Dec 15Now 80% overvalued after recent price riseOver the last 90 days, the stock has risen 22% to CA$0.77. The fair value is estimated to be CA$0.43, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 41% over the last 3 years. Meanwhile, the company became loss making.お知らせ • Dec 15Canopy Growth Corporation (TSX:WEED) entered into an arrangement agreement to acquire MTL Cannabis Corp. (CNSX:MTLC) for approximately CAD 120 million.Canopy Growth Corporation (TSX:WEED) entered into an arrangement agreement to acquire MTL Cannabis Corp. (CNSX:MTLC) for approximately CAD 120 million on December 14, 2025. Canopy Growth to acquire all of the issued and outstanding common shares in the capital of MTL on the basis of 0.32 of a common share of Canopy Growth (each whole share, a “Canopy Growth Share”) and CAD 0.144 in cash for each MTL Share, or approximately 38 million Canopy Growth Shares and CAD 17 million in cash in the aggregate. Pursuant to the Arrangement, each MC Shareholder will irrevocably, finally and fully release MTL, Canopy Growth and their respective affiliates from any and all obligations owing to such MC Shareholder pursuant to the Share Exchange Agreement, including for greater certainty, each MC Shareholder’s entitlement to anti-dilution rights pursuant to the Share Exchange Agreement (the “Release”) in exchange for such MC Shareholder’s pro rata entitlement to up to 2,956,391 (subject to reduction in certain circumstances) Canopy Growth Shares to be issued to the MC Shareholders pursuant to the Arrangement. The. Arrangement Agreement provides that a termination fee of CAD 4 million (the “Termination Fee”) will be payable by MTL upon termination of the Arrangement Agreement. Haywood Securities Inc. provided the MTL Cannabis Special Committee with an opinion that, as of December 14, 2025 and based upon and subject to the various assumptions, limitations, qualifications and other matters set forth in such opinion, the consideration to be received by the MTL Shareholders pursuant to the Transaction is fair, from a financial point of view, to MTL Shareholders. The Transaction was unanimously approved by the Board of Directors of Canopy Growth, as well as the Board of Directors of MTL Cannabis (with conflicted directors abstaining), following the unanimous recommendation of a special committee of the MTL Board of Directors (the “MTL Special Committee”). The MTL Special Committee and the Board of Directors unanimously recommended that MTL Shareholders vote in favour of the Transaction after determining the Transaction is fair to the MTL Shareholders and is in the best interests of MTL Cannabis. The Arrangement is subject to the conditions set forth in the Arrangement Agreement, including, among others: (i) approval by the Supreme Court of British Columbia (the “Court”) at a hearing upon the procedural and substantive fairness of the terms and conditions of the Arrangement; (ii) any approvals required under the Competition Act (Canada); and (iii) approval by the shareholders of MTL as required by applicable corporate and securities laws. The shareholders of MTL will be asked to vote on a resolution (the “Arrangement Resolution”) to, among other things, approve the Arrangement at a shareholder meeting to be called for such purpose, certain regulatory approvals, conditional approval of the Toronto Stock Exchange will have been obtained, including in respect of the listing and posting for trading of the Canopy Growth Shares issued as consideration for MTL Shares pursuant to the Arrangement and the MC Shareholder Consideration. Special meeting of MTL shareholders is expected to occur in February 2026, Expected closing by the end of February 2026. Jonathan Sherman of Cassels Brock& Blackwell LLP acted as legal advisor to Canopy Growth Corporation, Daniel Everall?of Farris LLP acted as legal advisor to MTL, Canaccord Genuity Corp. is acting as exclusive financial advisor to Canopy Growth. Paul Hastings LLP are acting as legal counsel to the Company, Haywood Securities Inc. is acting as exclusive financial advisor to the MTL Special Committee and provided a fairness opinion to the MTL Special Committee.New Risk • Dec 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.3x net interest cover). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Market cap is less than US$100m (CA$49.3m market cap, or US$35.8m).分析記事 • Nov 30Market Cool On MTL Cannabis Corp.'s (CSE:MTLC) Revenues Pushing Shares 32% LowerTo the annoyance of some shareholders, MTL Cannabis Corp. ( CSE:MTLC ) shares are down a considerable 32% in the last...Reported Earnings • Nov 30Second quarter 2026 earnings released: CA$0.071 loss per share (vs CA$0.011 profit in 2Q 2025)Second quarter 2026 results: CA$0.071 loss per share (down from CA$0.011 profit in 2Q 2025). Revenue: CA$20.6m (down 1.2% from 2Q 2025). Net loss: CA$8.32m (down CA$9.57m from profit in 2Q 2025).Board Change • Oct 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Tarek Ahmed was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.分析記事 • Oct 26A Look At The Intrinsic Value Of MTL Cannabis Corp. (CSE:MTLC)Key Insights MTL Cannabis' estimated fair value is CA$0.52 based on 2 Stage Free Cash Flow to Equity MTL Cannabis...Buy Or Sell Opportunity • Oct 03Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 85% to CA$0.63. The fair value is estimated to be CA$0.52, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last year. Meanwhile, the company has become profitable.Buy Or Sell Opportunity • Sep 18Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 86% to CA$0.67. The fair value is estimated to be CA$0.53, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last year. Meanwhile, the company has become profitable.お知らせ • Sep 10MTL Cannabis Corp., Annual General Meeting, Nov 18, 2025MTL Cannabis Corp., Annual General Meeting, Nov 18, 2025.Reported Earnings • Aug 31First quarter 2026 earnings released: EPS: CA$0 (vs CA$0.019 in 1Q 2025)First quarter 2026 results: EPS: CA$0 (down from CA$0.019 in 1Q 2025). Revenue: CA$20.7m (flat on 1Q 2025). Net loss: CA$44.4k (down 102% from profit in 1Q 2025).お知らせ • Aug 19MTL Cannabis Corp. announced that it expects to receive CAD 4 million in fundingMTL Cannabis Corp. announced that it has entered into an agreement with Centurion One Capital Corp. (the “Lead Agent” or “C1C”) as lead agent and sole bookrunner, in connection with a brokered private placement of units on a commercially reasonable efforts basis to issue 6,153,846 units at an issue price of CAD 0.65 for gross proceeds of CAD3,999,999.9 on August 19, 2025. The Lead Agent will have the option to sell up to an additional CAD 1,750,000 in Units (the “Agents’ Option”), exercisable at any time up to 48 hours prior to the closing date. Each Unit will consist of one common share of the Company and one-half of one common share purchase warrant. Each Warrant will entitle the holder to acquire one Common Share at an exercise price equal to a price of CAD 0.98 for a period of three years following the date of issuance. It is anticipated that certain insiders of the Company, the Lead Agent and certain affiliates may acquire Units in the Offering in amounts up to approximately 25% of the Offering. The securities issued under the LIFE Exemption will not be subject to a statutory hold period pursuant to applicable Canadian securities laws. The Offering is expected to close on or about August 22, 2025, or such other date as the Company and the Lead Agent may agree, and may close in one or more tranches. Closing is subject to customary conditions, including the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange (the “CSE”). The Units will be offered for sale in the provinces of British Columbia, Alberta, and Ontario, and such other jurisdictions outside of Canada and in the United States as may be agreed to by the Lead Agent and the Company. In the United States, the Units will be offered on a private placement basis pursuant to an exemption from the registration requirements of the United States Securities Act of 1933, as amended, and only to “accredited investors” as defined in Regulation D thereunder. The Offering will be conducted under the listed issuer financing exemption (the “LIFE Exemption”) pursuant to Part 5A of National Instrument 45-106 – Prospectus Exemptions and Canadian Securities Administrators Coordinated Blanket Order 45-953 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption.Reported Earnings • Jul 22Full year 2025 earnings released: EPS: CA$0.058 (vs CA$0.026 in FY 2024)Full year 2025 results: EPS: CA$0.058 (up from CA$0.026 in FY 2024). Revenue: CA$84.1m (up 29% from FY 2024). Net income: CA$6.83m (up 179% from FY 2024). Profit margin: 8.1% (up from 3.8% in FY 2024). The increase in margin was driven by higher revenue.New Risk • Jul 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 21% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Share price has been highly volatile over the past 3 months (21% average weekly change). Minor Risks Profit margins are more than 30% lower than last year (1.3% net profit margin). Market cap is less than US$100m (CA$39.2m market cap, or US$28.6m).お知らせ • Jul 17MTL Cannabis Corp. to Report Q4, 2025 Results on Jul 21, 2025MTL Cannabis Corp. announced that they will report Q4, 2025 results at 9:30 AM, US Eastern Standard Time on Jul 21, 2025分析記事 • Jun 17MTL Cannabis (CSE:MTLC) Has A Pretty Healthy Balance SheetDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...分析記事 • May 14Further Upside For MTL Cannabis Corp. (CSE:MTLC) Shares Could Introduce Price Risks After 27% BounceThose holding MTL Cannabis Corp. ( CSE:MTLC ) shares would be relieved that the share price has rebounded 27% in the...New Risk • May 12New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Share price has been highly volatile over the past 3 months (18% average weekly change). Minor Risks Profit margins are more than 30% lower than last year (1.3% net profit margin). Market cap is less than US$100m (CA$37.4m market cap, or US$26.8m).分析記事 • Mar 15Positive Sentiment Still Eludes MTL Cannabis Corp. (CSE:MTLC) Following 27% Share Price SlumpThe MTL Cannabis Corp. ( CSE:MTLC ) share price has softened a substantial 27% over the previous 30 days, handing back...Reported Earnings • Feb 28Third quarter 2025 earnings released: CA$0.01 loss per share (vs CA$0.002 loss in 3Q 2024)Third quarter 2025 results: CA$0.01 loss per share (further deteriorated from CA$0.002 loss in 3Q 2024). Revenue: CA$20.0m (up 3.2% from 3Q 2024). Net loss: CA$1.22m (loss widened 392% from 3Q 2024).分析記事 • Feb 25MTL Cannabis (CSE:MTLC) Ticks All The Boxes When It Comes To Earnings GrowthThe excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Recent Insider Transactions • Dec 23COO & Director recently bought CA$68k worth of stockOn the 18th of December, Michel Clément bought around 305k shares on-market at roughly CA$0.22 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Michel has been a buyer over the last 12 months, purchasing a net total of CA$91k worth in shares.Reported Earnings • Nov 29Second quarter 2025 earnings released: EPS: CA$0.011 (vs CA$0.021 in 2Q 2024)Second quarter 2025 results: EPS: CA$0.011 (down from CA$0.021 in 2Q 2024). Revenue: CA$20.9m (up 9.8% from 2Q 2024). Net income: CA$1.25m (down 38% from 2Q 2024). Profit margin: 6.0% (down from 11% in 2Q 2024). The decrease in margin was driven by higher expenses.分析記事 • Oct 31Is MTL Cannabis (CSE:MTLC) Using Too Much Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...お知らせ • Oct 15MTL Cannabis Corp., Annual General Meeting, Dec 12, 2024MTL Cannabis Corp., Annual General Meeting, Dec 12, 2024.Reported Earnings • Sep 01First quarter 2025 earnings releasedFirst quarter 2025 results: EPS: CA$0.019. Revenue: CA$20.7m (up 62% from 1Q 2024). Net income: CA$2.21m (up CA$2.39m from 1Q 2024). Profit margin: 11% (up from net loss in 1Q 2024). The move to profitability was driven by higher revenue.分析記事 • Aug 11Further Upside For MTL Cannabis Corp. (CSE:MTLC) Shares Could Introduce Price Risks After 26% BounceMTL Cannabis Corp. ( CSE:MTLC ) shareholders would be excited to see that the share price has had a great month...分析記事 • Aug 05The Strong Earnings Posted By MTL Cannabis (CSE:MTLC) Are A Good Indication Of The Strength Of The BusinessMTL Cannabis Corp. ( CSE:MTLC ) recently posted some strong earnings, and the market responded positively. We have done...New Risk • Jul 01New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (28% average weekly change). Minor Risk Market cap is less than US$100m (CA$33.3m market cap, or US$24.4m).Reported Earnings • Mar 06Third quarter 2023 earnings releasedThird quarter 2023 results: CA$0.038 loss per share. Revenue: CA$6.72m (up 30% from 3Q 2022). Net loss: CA$1.74m (loss narrowed 48% from 3Q 2022).お知らせ • Oct 18MTL Cannabis Corp. Announces CFO ChangesMTL Cannabis Corp. appointed Jason Nalewany as Chief Financial Officer. Mr. Nalewany brings over 18 years of financial expertise, having held pivotal roles in capital market strategies, fundraising, M&A advisory, and go-public mandates. He has previously held the CFO role at Montreal Cannabis Medical Inc., in addition to previously holding senior finance roles at MediPharm Labs, where he helped support the initial development of the company and drive more than $129 million of sales and $29 million EBITDA in its first full year of operations, and Aurora Cannabis Inc., where he played a significant role in Aurora's $3.2 billion merger with MedReleaf Corp. His extensive experience also includes strategic roles at Methanex Corporation, FTI Consulting Inc., and MNP LLP. Mr. Nalewany began his career in the audit and assurance practice at PricewaterhouseCoopers LLP, Canada. He is a Canadian Chartered Professional Accountant (CPA, CA) and holds a Bachelor of Commerce degree from the University of Victoria. Mr. Nalewany will be replacing Peili Miao, who previously held the position at MTL Cannabis Corp.Board Change • Aug 22Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Director Tarek Ahmed was the last director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.株主還元MTLCCA PharmaceuticalsCA 市場7D0%-3.3%1.1%1Y72.7%48.1%29.6%株主還元を見る業界別リターン: MTLC過去 1 年間で48.1 % の収益を上げたCanadian Pharmaceuticals業界を上回りました。リターン対市場: MTLC過去 1 年間で29.6 % の収益を上げたCanadian市場を上回りました。価格変動Is MTLC's price volatile compared to industry and market?MTLC volatilityMTLC Average Weekly Movement7.5%Pharmaceuticals Industry Average Movement10.0%Market Average Movement9.6%10% most volatile stocks in CA Market16.8%10% least volatile stocks in CA Market3.7%安定した株価: MTLC 、 Canadian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: MTLCの 週次ボラティリティ は、過去 1 年間で18%から7%に減少しました。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/an/aMike Perronwww.mtlcannabis.caMTL Cannabis Corp.は子会社を通じて、カナダで娯楽用および医療用の大麻製品の栽培と生産に従事している。同社はドライフラワー、プレロール、ハッシュ製品を提供している。また、プライマリーケアチームと直接連携し、病状に苦しむ患者に専門的なカンナビノイド療法サービスを提供するクリニックも運営している。本社はカナダのポワンクレール。もっと見るMTL Cannabis Corp. 基礎のまとめMTL Cannabis の収益と売上を時価総額と比較するとどうか。MTLC 基礎統計学時価総額CA$68.57m収益（TTM）-CA$3.10m売上高(TTM)CA$81.00m0.8xP/Sレシオ-22.1xPER（株価収益率MTLC は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計MTLC 損益計算書（TTM）収益CA$81.00m売上原価CA$34.10m売上総利益CA$46.89mその他の費用CA$49.99m収益-CA$3.10m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.026グロス・マージン57.90%純利益率-3.83%有利子負債／自己資本比率116.6%MTLC の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/03/16 18:41終値2026/03/13 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋MTL Cannabis Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Mar 02Third quarter 2026 earnings released: EPS: CA$0.006 (vs CA$0.01 loss in 3Q 2025)Third quarter 2026 results: EPS: CA$0.006 (up from CA$0.01 loss in 3Q 2025). Revenue: CA$17.2m (down 14% from 3Q 2025). Net income: CA$672.9k (up CA$1.89m from 3Q 2025). Profit margin: 3.9% (up from net loss in 3Q 2025). The move to profitability was driven by lower expenses.
Buy Or Sell Opportunity • Dec 15Now 80% overvalued after recent price riseOver the last 90 days, the stock has risen 22% to CA$0.77. The fair value is estimated to be CA$0.43, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 41% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Dec 15Canopy Growth Corporation (TSX:WEED) entered into an arrangement agreement to acquire MTL Cannabis Corp. (CNSX:MTLC) for approximately CAD 120 million.Canopy Growth Corporation (TSX:WEED) entered into an arrangement agreement to acquire MTL Cannabis Corp. (CNSX:MTLC) for approximately CAD 120 million on December 14, 2025. Canopy Growth to acquire all of the issued and outstanding common shares in the capital of MTL on the basis of 0.32 of a common share of Canopy Growth (each whole share, a “Canopy Growth Share”) and CAD 0.144 in cash for each MTL Share, or approximately 38 million Canopy Growth Shares and CAD 17 million in cash in the aggregate. Pursuant to the Arrangement, each MC Shareholder will irrevocably, finally and fully release MTL, Canopy Growth and their respective affiliates from any and all obligations owing to such MC Shareholder pursuant to the Share Exchange Agreement, including for greater certainty, each MC Shareholder’s entitlement to anti-dilution rights pursuant to the Share Exchange Agreement (the “Release”) in exchange for such MC Shareholder’s pro rata entitlement to up to 2,956,391 (subject to reduction in certain circumstances) Canopy Growth Shares to be issued to the MC Shareholders pursuant to the Arrangement. The. Arrangement Agreement provides that a termination fee of CAD 4 million (the “Termination Fee”) will be payable by MTL upon termination of the Arrangement Agreement. Haywood Securities Inc. provided the MTL Cannabis Special Committee with an opinion that, as of December 14, 2025 and based upon and subject to the various assumptions, limitations, qualifications and other matters set forth in such opinion, the consideration to be received by the MTL Shareholders pursuant to the Transaction is fair, from a financial point of view, to MTL Shareholders. The Transaction was unanimously approved by the Board of Directors of Canopy Growth, as well as the Board of Directors of MTL Cannabis (with conflicted directors abstaining), following the unanimous recommendation of a special committee of the MTL Board of Directors (the “MTL Special Committee”). The MTL Special Committee and the Board of Directors unanimously recommended that MTL Shareholders vote in favour of the Transaction after determining the Transaction is fair to the MTL Shareholders and is in the best interests of MTL Cannabis. The Arrangement is subject to the conditions set forth in the Arrangement Agreement, including, among others: (i) approval by the Supreme Court of British Columbia (the “Court”) at a hearing upon the procedural and substantive fairness of the terms and conditions of the Arrangement; (ii) any approvals required under the Competition Act (Canada); and (iii) approval by the shareholders of MTL as required by applicable corporate and securities laws. The shareholders of MTL will be asked to vote on a resolution (the “Arrangement Resolution”) to, among other things, approve the Arrangement at a shareholder meeting to be called for such purpose, certain regulatory approvals, conditional approval of the Toronto Stock Exchange will have been obtained, including in respect of the listing and posting for trading of the Canopy Growth Shares issued as consideration for MTL Shares pursuant to the Arrangement and the MC Shareholder Consideration. Special meeting of MTL shareholders is expected to occur in February 2026, Expected closing by the end of February 2026. Jonathan Sherman of Cassels Brock& Blackwell LLP acted as legal advisor to Canopy Growth Corporation, Daniel Everall?of Farris LLP acted as legal advisor to MTL, Canaccord Genuity Corp. is acting as exclusive financial advisor to Canopy Growth. Paul Hastings LLP are acting as legal counsel to the Company, Haywood Securities Inc. is acting as exclusive financial advisor to the MTL Special Committee and provided a fairness opinion to the MTL Special Committee.
New Risk • Dec 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.3x net interest cover). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Market cap is less than US$100m (CA$49.3m market cap, or US$35.8m).
分析記事 • Nov 30Market Cool On MTL Cannabis Corp.'s (CSE:MTLC) Revenues Pushing Shares 32% LowerTo the annoyance of some shareholders, MTL Cannabis Corp. ( CSE:MTLC ) shares are down a considerable 32% in the last...
Reported Earnings • Nov 30Second quarter 2026 earnings released: CA$0.071 loss per share (vs CA$0.011 profit in 2Q 2025)Second quarter 2026 results: CA$0.071 loss per share (down from CA$0.011 profit in 2Q 2025). Revenue: CA$20.6m (down 1.2% from 2Q 2025). Net loss: CA$8.32m (down CA$9.57m from profit in 2Q 2025).
Reported Earnings • Mar 02Third quarter 2026 earnings released: EPS: CA$0.006 (vs CA$0.01 loss in 3Q 2025)Third quarter 2026 results: EPS: CA$0.006 (up from CA$0.01 loss in 3Q 2025). Revenue: CA$17.2m (down 14% from 3Q 2025). Net income: CA$672.9k (up CA$1.89m from 3Q 2025). Profit margin: 3.9% (up from net loss in 3Q 2025). The move to profitability was driven by lower expenses.
Buy Or Sell Opportunity • Dec 15Now 80% overvalued after recent price riseOver the last 90 days, the stock has risen 22% to CA$0.77. The fair value is estimated to be CA$0.43, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 41% over the last 3 years. Meanwhile, the company became loss making.
お知らせ • Dec 15Canopy Growth Corporation (TSX:WEED) entered into an arrangement agreement to acquire MTL Cannabis Corp. (CNSX:MTLC) for approximately CAD 120 million.Canopy Growth Corporation (TSX:WEED) entered into an arrangement agreement to acquire MTL Cannabis Corp. (CNSX:MTLC) for approximately CAD 120 million on December 14, 2025. Canopy Growth to acquire all of the issued and outstanding common shares in the capital of MTL on the basis of 0.32 of a common share of Canopy Growth (each whole share, a “Canopy Growth Share”) and CAD 0.144 in cash for each MTL Share, or approximately 38 million Canopy Growth Shares and CAD 17 million in cash in the aggregate. Pursuant to the Arrangement, each MC Shareholder will irrevocably, finally and fully release MTL, Canopy Growth and their respective affiliates from any and all obligations owing to such MC Shareholder pursuant to the Share Exchange Agreement, including for greater certainty, each MC Shareholder’s entitlement to anti-dilution rights pursuant to the Share Exchange Agreement (the “Release”) in exchange for such MC Shareholder’s pro rata entitlement to up to 2,956,391 (subject to reduction in certain circumstances) Canopy Growth Shares to be issued to the MC Shareholders pursuant to the Arrangement. The. Arrangement Agreement provides that a termination fee of CAD 4 million (the “Termination Fee”) will be payable by MTL upon termination of the Arrangement Agreement. Haywood Securities Inc. provided the MTL Cannabis Special Committee with an opinion that, as of December 14, 2025 and based upon and subject to the various assumptions, limitations, qualifications and other matters set forth in such opinion, the consideration to be received by the MTL Shareholders pursuant to the Transaction is fair, from a financial point of view, to MTL Shareholders. The Transaction was unanimously approved by the Board of Directors of Canopy Growth, as well as the Board of Directors of MTL Cannabis (with conflicted directors abstaining), following the unanimous recommendation of a special committee of the MTL Board of Directors (the “MTL Special Committee”). The MTL Special Committee and the Board of Directors unanimously recommended that MTL Shareholders vote in favour of the Transaction after determining the Transaction is fair to the MTL Shareholders and is in the best interests of MTL Cannabis. The Arrangement is subject to the conditions set forth in the Arrangement Agreement, including, among others: (i) approval by the Supreme Court of British Columbia (the “Court”) at a hearing upon the procedural and substantive fairness of the terms and conditions of the Arrangement; (ii) any approvals required under the Competition Act (Canada); and (iii) approval by the shareholders of MTL as required by applicable corporate and securities laws. The shareholders of MTL will be asked to vote on a resolution (the “Arrangement Resolution”) to, among other things, approve the Arrangement at a shareholder meeting to be called for such purpose, certain regulatory approvals, conditional approval of the Toronto Stock Exchange will have been obtained, including in respect of the listing and posting for trading of the Canopy Growth Shares issued as consideration for MTL Shares pursuant to the Arrangement and the MC Shareholder Consideration. Special meeting of MTL shareholders is expected to occur in February 2026, Expected closing by the end of February 2026. Jonathan Sherman of Cassels Brock& Blackwell LLP acted as legal advisor to Canopy Growth Corporation, Daniel Everall?of Farris LLP acted as legal advisor to MTL, Canaccord Genuity Corp. is acting as exclusive financial advisor to Canopy Growth. Paul Hastings LLP are acting as legal counsel to the Company, Haywood Securities Inc. is acting as exclusive financial advisor to the MTL Special Committee and provided a fairness opinion to the MTL Special Committee.
New Risk • Dec 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Canadian stocks, typically moving 15% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.3x net interest cover). Minor Risks Share price has been volatile over the past 3 months (15% average weekly change). Market cap is less than US$100m (CA$49.3m market cap, or US$35.8m).
分析記事 • Nov 30Market Cool On MTL Cannabis Corp.'s (CSE:MTLC) Revenues Pushing Shares 32% LowerTo the annoyance of some shareholders, MTL Cannabis Corp. ( CSE:MTLC ) shares are down a considerable 32% in the last...
Reported Earnings • Nov 30Second quarter 2026 earnings released: CA$0.071 loss per share (vs CA$0.011 profit in 2Q 2025)Second quarter 2026 results: CA$0.071 loss per share (down from CA$0.011 profit in 2Q 2025). Revenue: CA$20.6m (down 1.2% from 2Q 2025). Net loss: CA$8.32m (down CA$9.57m from profit in 2Q 2025).
Board Change • Oct 29Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Tarek Ahmed was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
分析記事 • Oct 26A Look At The Intrinsic Value Of MTL Cannabis Corp. (CSE:MTLC)Key Insights MTL Cannabis' estimated fair value is CA$0.52 based on 2 Stage Free Cash Flow to Equity MTL Cannabis...
Buy Or Sell Opportunity • Oct 03Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 85% to CA$0.63. The fair value is estimated to be CA$0.52, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last year. Meanwhile, the company has become profitable.
Buy Or Sell Opportunity • Sep 18Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 86% to CA$0.67. The fair value is estimated to be CA$0.53, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last year. Meanwhile, the company has become profitable.
お知らせ • Sep 10MTL Cannabis Corp., Annual General Meeting, Nov 18, 2025MTL Cannabis Corp., Annual General Meeting, Nov 18, 2025.
Reported Earnings • Aug 31First quarter 2026 earnings released: EPS: CA$0 (vs CA$0.019 in 1Q 2025)First quarter 2026 results: EPS: CA$0 (down from CA$0.019 in 1Q 2025). Revenue: CA$20.7m (flat on 1Q 2025). Net loss: CA$44.4k (down 102% from profit in 1Q 2025).
お知らせ • Aug 19MTL Cannabis Corp. announced that it expects to receive CAD 4 million in fundingMTL Cannabis Corp. announced that it has entered into an agreement with Centurion One Capital Corp. (the “Lead Agent” or “C1C”) as lead agent and sole bookrunner, in connection with a brokered private placement of units on a commercially reasonable efforts basis to issue 6,153,846 units at an issue price of CAD 0.65 for gross proceeds of CAD3,999,999.9 on August 19, 2025. The Lead Agent will have the option to sell up to an additional CAD 1,750,000 in Units (the “Agents’ Option”), exercisable at any time up to 48 hours prior to the closing date. Each Unit will consist of one common share of the Company and one-half of one common share purchase warrant. Each Warrant will entitle the holder to acquire one Common Share at an exercise price equal to a price of CAD 0.98 for a period of three years following the date of issuance. It is anticipated that certain insiders of the Company, the Lead Agent and certain affiliates may acquire Units in the Offering in amounts up to approximately 25% of the Offering. The securities issued under the LIFE Exemption will not be subject to a statutory hold period pursuant to applicable Canadian securities laws. The Offering is expected to close on or about August 22, 2025, or such other date as the Company and the Lead Agent may agree, and may close in one or more tranches. Closing is subject to customary conditions, including the receipt of all necessary regulatory approvals, including the approval of the Canadian Securities Exchange (the “CSE”). The Units will be offered for sale in the provinces of British Columbia, Alberta, and Ontario, and such other jurisdictions outside of Canada and in the United States as may be agreed to by the Lead Agent and the Company. In the United States, the Units will be offered on a private placement basis pursuant to an exemption from the registration requirements of the United States Securities Act of 1933, as amended, and only to “accredited investors” as defined in Regulation D thereunder. The Offering will be conducted under the listed issuer financing exemption (the “LIFE Exemption”) pursuant to Part 5A of National Instrument 45-106 – Prospectus Exemptions and Canadian Securities Administrators Coordinated Blanket Order 45-953 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption.
Reported Earnings • Jul 22Full year 2025 earnings released: EPS: CA$0.058 (vs CA$0.026 in FY 2024)Full year 2025 results: EPS: CA$0.058 (up from CA$0.026 in FY 2024). Revenue: CA$84.1m (up 29% from FY 2024). Net income: CA$6.83m (up 179% from FY 2024). Profit margin: 8.1% (up from 3.8% in FY 2024). The increase in margin was driven by higher revenue.
New Risk • Jul 21New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 21% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Share price has been highly volatile over the past 3 months (21% average weekly change). Minor Risks Profit margins are more than 30% lower than last year (1.3% net profit margin). Market cap is less than US$100m (CA$39.2m market cap, or US$28.6m).
お知らせ • Jul 17MTL Cannabis Corp. to Report Q4, 2025 Results on Jul 21, 2025MTL Cannabis Corp. announced that they will report Q4, 2025 results at 9:30 AM, US Eastern Standard Time on Jul 21, 2025
分析記事 • Jun 17MTL Cannabis (CSE:MTLC) Has A Pretty Healthy Balance SheetDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 • May 14Further Upside For MTL Cannabis Corp. (CSE:MTLC) Shares Could Introduce Price Risks After 27% BounceThose holding MTL Cannabis Corp. ( CSE:MTLC ) shares would be relieved that the share price has rebounded 27% in the...
New Risk • May 12New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Share price has been highly volatile over the past 3 months (18% average weekly change). Minor Risks Profit margins are more than 30% lower than last year (1.3% net profit margin). Market cap is less than US$100m (CA$37.4m market cap, or US$26.8m).
分析記事 • Mar 15Positive Sentiment Still Eludes MTL Cannabis Corp. (CSE:MTLC) Following 27% Share Price SlumpThe MTL Cannabis Corp. ( CSE:MTLC ) share price has softened a substantial 27% over the previous 30 days, handing back...
Reported Earnings • Feb 28Third quarter 2025 earnings released: CA$0.01 loss per share (vs CA$0.002 loss in 3Q 2024)Third quarter 2025 results: CA$0.01 loss per share (further deteriorated from CA$0.002 loss in 3Q 2024). Revenue: CA$20.0m (up 3.2% from 3Q 2024). Net loss: CA$1.22m (loss widened 392% from 3Q 2024).
分析記事 • Feb 25MTL Cannabis (CSE:MTLC) Ticks All The Boxes When It Comes To Earnings GrowthThe excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Recent Insider Transactions • Dec 23COO & Director recently bought CA$68k worth of stockOn the 18th of December, Michel Clément bought around 305k shares on-market at roughly CA$0.22 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Michel has been a buyer over the last 12 months, purchasing a net total of CA$91k worth in shares.
Reported Earnings • Nov 29Second quarter 2025 earnings released: EPS: CA$0.011 (vs CA$0.021 in 2Q 2024)Second quarter 2025 results: EPS: CA$0.011 (down from CA$0.021 in 2Q 2024). Revenue: CA$20.9m (up 9.8% from 2Q 2024). Net income: CA$1.25m (down 38% from 2Q 2024). Profit margin: 6.0% (down from 11% in 2Q 2024). The decrease in margin was driven by higher expenses.
分析記事 • Oct 31Is MTL Cannabis (CSE:MTLC) Using Too Much Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
お知らせ • Oct 15MTL Cannabis Corp., Annual General Meeting, Dec 12, 2024MTL Cannabis Corp., Annual General Meeting, Dec 12, 2024.
Reported Earnings • Sep 01First quarter 2025 earnings releasedFirst quarter 2025 results: EPS: CA$0.019. Revenue: CA$20.7m (up 62% from 1Q 2024). Net income: CA$2.21m (up CA$2.39m from 1Q 2024). Profit margin: 11% (up from net loss in 1Q 2024). The move to profitability was driven by higher revenue.
分析記事 • Aug 11Further Upside For MTL Cannabis Corp. (CSE:MTLC) Shares Could Introduce Price Risks After 26% BounceMTL Cannabis Corp. ( CSE:MTLC ) shareholders would be excited to see that the share price has had a great month...
分析記事 • Aug 05The Strong Earnings Posted By MTL Cannabis (CSE:MTLC) Are A Good Indication Of The Strength Of The BusinessMTL Cannabis Corp. ( CSE:MTLC ) recently posted some strong earnings, and the market responded positively. We have done...
New Risk • Jul 01New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risks No financial data reported. Share price has been highly volatile over the past 3 months (28% average weekly change). Minor Risk Market cap is less than US$100m (CA$33.3m market cap, or US$24.4m).
Reported Earnings • Mar 06Third quarter 2023 earnings releasedThird quarter 2023 results: CA$0.038 loss per share. Revenue: CA$6.72m (up 30% from 3Q 2022). Net loss: CA$1.74m (loss narrowed 48% from 3Q 2022).
お知らせ • Oct 18MTL Cannabis Corp. Announces CFO ChangesMTL Cannabis Corp. appointed Jason Nalewany as Chief Financial Officer. Mr. Nalewany brings over 18 years of financial expertise, having held pivotal roles in capital market strategies, fundraising, M&A advisory, and go-public mandates. He has previously held the CFO role at Montreal Cannabis Medical Inc., in addition to previously holding senior finance roles at MediPharm Labs, where he helped support the initial development of the company and drive more than $129 million of sales and $29 million EBITDA in its first full year of operations, and Aurora Cannabis Inc., where he played a significant role in Aurora's $3.2 billion merger with MedReleaf Corp. His extensive experience also includes strategic roles at Methanex Corporation, FTI Consulting Inc., and MNP LLP. Mr. Nalewany began his career in the audit and assurance practice at PricewaterhouseCoopers LLP, Canada. He is a Canadian Chartered Professional Accountant (CPA, CA) and holds a Bachelor of Commerce degree from the University of Victoria. Mr. Nalewany will be replacing Peili Miao, who previously held the position at MTL Cannabis Corp.
Board Change • Aug 22Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Director Tarek Ahmed was the last director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
